Lilly’s Mirikizumab shows reduction of Intestinal Inflammation in Crohn’s Disease
Eli Lilly and Company revealed on Monday, new efficiency and safety results from the Phase 2 SERENITY trial assessing Mirikizumab
Read more
Latest
ViiV Healthcare’s two-drug combo non-inferior to 3-drug HIV regimen
ViiV Healthcare’s GEMINI studies showed that the 2-drug regimen (2DR) of dolutegravir plus lamivudine, appeared to have non-inferior potency in
Read more
Roche’s logistics challenges lead to NHS testing delays in the UK
UK clinicians are being advised to “think carefully” before ordering tests as pharma group Roche is experiencing logistical challenges due
Read more
BMS boosts cardiovascular pipeline with $13.1 Billion MyoKardia buy
Bristol Myers Squibb is strengthening its cardiovascular pipeline through a $13.1 Billion acquisition of biotech firm MyoKardia. The $13.1 Billion
Read more
AstraZeneca’s FARXIGA® gets designation for Chronic Kidney Disease
AstraZeneca’s FARXIGA® was granted Breakthrough Therapy Designation (BTD) in the U.S. for Chronic Kidney Disease, following the DAPA-CKD Phase III
Read more
Donald Trump treated with experimental Monoclonal Antibody cocktail
United States President Donald Trump has been administered with an intravenous dose of Regeneron Pharmaceuticals experimental COVID-19 treatment REGN-COV2, a
Read more
Abbott enrolls first patient in SCS/CMM trial to treat chronic low back pain
Abbott declared the first patient has been enrolled in the DISTINCT study (Dorsal spInal cord STImulatioN vs mediCal management for
Read more
Janssen’s Golimumab gets FDA nod for pediatric use in Juvenile Arthritis
Janssen’s Golimumab, a human monoclonal antibody used as an immunosuppressive drug and sold under the brand name Simponi, has received
Read more
J&J Covid-19 Vaccine produces a strong neutralizing antibody response
Interim analysis of the J&J COVID-19 vaccine candidate (JNJ-78436735) in the ongoing Phase 1/2a clinical trial has shown that a
Read more
Roche acquires Irish biotch Inflazome for €380m
Irish biotechnology firm Inflazome announced today that it has closed a share purchase agreement with Swiss pharma giant Roche in
Read more